Identification of key processes underlying cancer phenotypes using biologic pathway analysis
about
Systems analysis of high-throughput dataNetwork-based identification of biomarkers coexpressed with multiple pathwaysHuman cancer protein-protein interaction network: a structural perspectiveA chemocentric approach to the identification of cancer targetsAssociation of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cellsA signal transduction score flow algorithm for cyclic cellular pathway analysis, which combines transcriptome and ChIP-seq data.Assessing the impact of mutations found in next generation sequencing data over human signaling pathways.Accurate and reliable cancer classification based on probabilistic inference of pathway activity.Heat acclimation memory: do the kinetics of the deacclimated transcriptome predispose to rapid reacclimation and cytoprotection?SLEPR: a sample-level enrichment-based pathway ranking method -- seeking biological themes through pathway-level consistencyInferring pathway activity toward precise disease classificationGene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance.Consistency, comprehensiveness, and compatibility of pathway databasesImproved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modulesEnrichment map: a network-based method for gene-set enrichment visualization and interpretation.Detecting cancer gene networks characterized by recurrent genomic alterations in a population.The PathOlogist: an automated tool for pathway-centric analysisProtein networks as logic functions in development and cancer.Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.A decade of systems biologySensitive detection of pathway perturbations in cancersMultivariate inference of pathway activity in host immunity and response to therapeutics.Merging experimental data and in silico analysis: a systems-level approach to autoimmune disease and cancer.Identifying genetic marker sets associated with phenotypes via an efficient adaptive score test.Understanding disease mechanisms with models of signaling pathway activities.Topology of molecular interaction networks.Network features suggest new hepatocellular carcinoma treatment strategiesAn integrated approach to uncover driver genes in breast cancer methylation genomes.Translational disease interpretation with molecular networks.Using random walks to identify cancer-associated modules in expression dataMicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotypeGene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progressionUsing activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityCytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.Pathway-based personalized analysis of cancerUsing prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification.Inferring the functional effect of gene expression changes in signaling pathways.Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM.
P2860
Q27023883-8995AD81-DB2E-4A5C-868A-F728022ECD37Q28397059-71A1A7B2-0052-4044-9CF5-A8C92648FC91Q28472174-F497F243-3CB4-46C9-8A17-29B6CD5AD147Q28482507-87C0F92D-B2B6-4837-A920-2E98A1A5BA92Q28744086-9C41F133-4167-4559-AD2D-6497615926ECQ30572345-99C5B875-A3F6-45E7-AA3D-50763E692C65Q30934680-C9975716-F7D2-44D4-9682-3AF3D4AEB59AQ30974030-A05E720E-6AFB-4C19-B1D6-2CB6EB499C1EQ33359118-5E9228AE-CC56-496F-9C59-60779B092892Q33372132-DA99C1E7-A9B7-4B87-AEC8-CDD3D90EECF6Q33383213-97761E50-83B4-408A-890E-7F1C0E97E750Q33559278-959476AA-A18B-44A8-A373-715C613D5F6CQ33597322-E1D91118-2DC0-4D84-9809-494571BAEE95Q33638312-129AEEAB-3208-4D26-BE35-59FF2AA762FFQ33685013-7F350C3F-2FBF-482D-98AD-570597C672E1Q33738285-743F0F9D-B614-4512-BB73-C7F99B5C0521Q33749961-BFAA6F7A-2F05-4435-B1DF-8B1B9550B1C4Q33808510-62E700EA-36A2-40B4-B538-2EEE536D7830Q33890015-EDEF8E49-E67D-4A4E-A455-257E8397E1EDQ34042616-46E6C301-BB9B-447F-80D2-ED6F8A1E24C4Q34124475-80B52645-9D11-462F-8FE2-7518B94CF942Q34124493-864FF004-0C4D-48C7-BF8C-62C2AF5B0AB7Q34247915-9B7D751C-F4F9-46FB-9D80-285BD7AA98F8Q34249561-83798A55-BD84-47F9-8990-FB2BC7C7D84DQ34274318-76FAB692-A5E5-4196-BA93-2072BF9CFE47Q34317223-07B960FD-48E0-40D3-B90A-5DB00E31A31AQ34422921-699307E4-EFD8-4012-A59F-37F22C8520AAQ34508185-0916CF15-7DDB-4B66-9A59-1CB80672AA9BQ34539069-8CA89E99-0E5B-47DD-8E8B-9D079BD1D2C6Q34665735-0E0C24D1-23F5-4631-B00D-AFB306646802Q34991710-1BCF4779-ADB3-436D-A323-7762BC15E64FQ35017720-0BE1B9BD-2E6F-4F9C-9BB5-2F25F6FD9D95Q35176381-E9ECA101-40BD-4A45-822A-B79E300CA080Q35840649-7A1CEE6C-5D4D-4495-A5C1-D001155F3812Q36382520-D2246DDE-6FB7-4251-A575-E13BA2AFAF44Q36641687-E7192F5A-DAA1-4372-B1D0-7DA6C4BE9075Q36782228-04B0C916-61AE-4610-9FD7-E10051228609Q36910040-DB5C36EC-E617-467D-8B24-6B23E383CD0BQ36954066-7F870FF9-8A3E-4589-BFEB-2984CB0FBBF0Q36960648-2D5924E5-9432-48C3-95CD-EE5E65E54DF1
P2860
Identification of key processes underlying cancer phenotypes using biologic pathway analysis
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Identification of key processe ...... sing biologic pathway analysis
@ast
Identification of key processe ...... sing biologic pathway analysis
@en
type
label
Identification of key processe ...... sing biologic pathway analysis
@ast
Identification of key processe ...... sing biologic pathway analysis
@en
prefLabel
Identification of key processe ...... sing biologic pathway analysis
@ast
Identification of key processe ...... sing biologic pathway analysis
@en
P2860
P1433
P1476
Identification of key processe ...... sing biologic pathway analysis
@en
P2093
Carl F Schaefer
Kenneth H Buetow
P2860
P356
10.1371/JOURNAL.PONE.0000425
P407
P50
P577
2007-05-09T00:00:00Z